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Abstract Cbl is an adaptor protein and E3 ligase that
plays both positive and negative roles in several signaling
pathways that affect various cellular functions. Tyrosine
737 is unique to Cbl and phosphorylated by Src family
kinases. Phosphorylated CblY737 creates a binding site for
the p85 regulatory subunit of phosphatidylinositol 3 kinase
(PI3K) that also plays an important role in the regulation of
bone homeostasis. To investigate the role of Cbl–PI3K
interaction in bone homeostasis, we examined knock-in
mice in which the PI3K binding site on Cbl was ablated
due to the substitution of tyrosine 737 to phenylalanine
(Cbl
YF/YF, YF mice). We previously reported that bone
volume in these mice is increased due to decreased
osteoclast function (Adapala et al., J Biol Chem
285:36745–36758, 19). Here, we report that YF mice also
have increased bone formation and osteoblast numbers. In
ex vivo cultures bone marrow-derived YF osteoblasts
showed increased Col1A expression and their proliferation
was also signiﬁcantly augmented. Moreover, proliferation
of MC3T3-E1 cells was increased after treatment with
conditioned medium generated by culturing YF bone
marrow stromal cells. Expression of stromal derived factor-
1 (SDF-1) was increased in YF bone marrow stromal cells
compared to wild type. Increased immunostaining of SDF-
1 and CXCR4 was observed in YF bone marrow stromal
cells compared to wild type. Treatment of YF condition
medium with neutralizing anti-SDF-1 and anti-CXCR4
antibodies attenuated MC3T3-E1 cell proliferation. Cumu-
latively, these results show that abrogation of Cbl–PI3K
interaction perturbs bone homeostasis, affecting both
osteoclast function and osteoblast proliferation.
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Bone is a dynamic organ that provides support and pro-
tection to vital organs. Bone also plays a role in the reg-
ulation of calcium homeostasis. The effects of two cell
types, osteoblasts and osteoclasts, are critical for main-
taining proper bone mass and shape. Osteoclasts are a
member of the monocyte/macrophage family, while oste-
oblasts are of mesenchymal origin and responsible for
mineralizing bone matrix [1].
Cbl and Cbl-b are highly homologous members of a
family of adaptor proteins that promote assembly of sig-
naling complexes downstream of several receptors [2].
Both function as E3 ubiquitin ligases that regulate
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ticipate in growth factor, cytokine, and integrin-mediated
signaling pathways in various cell types. Tyrosine phos-
phorylation of Cbl upon receptor activation is one of the
most common signaling phenomena shown to promote
both its E3 ubiquitin ligase activity and adaptor function
[2].
Despite the marked effect of mutating Cbl [3, 4]o r
reducing its expression in vitro to affect osteoclast activity
[5], Cbl
-/- mice have a mild bone phenotype manifested
primarily during endochondral bone formation [6]. In
contrast, absence of Cbl-b protein in mice results in oste-
openia due to osteoclast hyperactivity [7]. In spite of sig-
niﬁcant homology between Cbl and Cbl-b proteins, single
knockouts of Cbl and Cbl-b have distinct bone phenotypes,
suggesting speciﬁc roles for each protein in bone homeo-
stasis. However, Cbl/Cbl-b double knockout mice die in
utero around E10.5 [8], suggesting that Cbl and Cbl-b also
have overlapping functions. The major structural difference
that could contribute to the unique function(s) of Cbl
proteins includes a tyrosine present only in Cbl (CblY737),
which when phosphorylated binds to the SH2 domain of
the p85 subunit of phosphatidylinositol 3 kinase (PI3K)
[9–11]. Other investigators have shown that Tyr
737 is
among several Tyr residues that are phosphorylated by Src
family kinases [12] and that when phosphorylated binds to
the SH2 domain of the regulatory p85 subunit of PI3K
[10, 11]. The absence of this residue in Cbl-b highlights a
potential divergence in the role and mode of action of these
two highly similar regulatory proteins, although this has
not been examined with respect to osteoclast or osteoblast
biology.
PI3Ks are a class of enzymes that phosphorylate phos-
phatidylinositol and its derivatives and regulate cell
growth, the cytoskeleton, and cell survival [13]. PI3K
activation in various cell types, including osteoblasts, is
often associated with increased tyrosine phosphorylation
induced by growth and differentiation factors. The impor-
tance of PI3K in osteoblast function has been established
[14, 15]. In several cell types, Cbl is known to be a major
protein that interacts with PI3K and regulates its activity
[11, 16]. Downregulation of Cbl induced by twist hap-
loinsufﬁciency in Saethre-Chotzen syndrome results in
increased PI3K/AKT signaling and osteoblast proliferation
[17]. In humans, osteoblasts expressing mutated FGFR2
levels of PI3K are decreased. The decreased PI3K signal-
ing in response to FGFR2 activation is due to increased
Cbl–PI3K molecular interaction mediated by the Cbl Y731
residue, which results in increased PI3K ubiquitylation and
proteasome degradation [18]. We recently reported that, on
the one hand, the Cbl–PI3K complex negatively regulates
osteoclast differentiation and survival while, on the other
hand, it positively inﬂuences osteoclast function [19].
In this report, we continued to study the role of Cbl–
PI3K interaction in the skeletal system. Our results indi-
cated that abrogation of the Cbl–PI3K interaction resulted
in increased bone mass and increased trabecular and cor-
tical bone volumes. The altered geometry of bone due to
increased volume also resulted in increased mechanical
properties. While osteoblast numbers were increased in
mice, ex vivo differentiation and survival of the YF
osteoblast was not signiﬁcantly affected. Analysis of the
conditioned medium derived from culturing YF bone
marrow stromal cells, as well as the expression analysis of
cells, showed increased expression of stromal cell derived
factor-1 (SDF-1) and its receptor, CXCR4. Antibody-
mediated ablation of SDF-1 activity attenuated cell pro-
liferation. Taken together, these data and our previously
published work suggest that abrogation of Cbl–PI3K
interaction perturbs bone homeostasis, affecting both
osteoclast function and osteoblast proliferation.
Materials and Methods
Mice Colony
The generation of CblY737F mice has been previously
described [20]. Mice were maintained in a mixed C57BL/
6 9 129SvJ background, and experiments were performed
in compliance with the Institutional Animal Care and Use
Committee at Temple University.
Histological Analysis
To label the skeleton, calcein (i.p., 10 mg/kg body weight)
was injected 9 and 2 days before death. After death, tibiae
and femora of 12-week-old male mice were excised and
cleaned of soft tissue. Bones were processed as previously
described [21]. Longitudinal sections (5 lM) were used to
measure the ﬂuorochrome label and then deplasticized and
stained with Masson trichrome, as described previously
[21]. Histomorphometry was performed on three tissue
sections per limb using a Nikon 800 ﬂuorescence micro-
scope linked to a Bioquant Osteo II system (R&M Bio-
metrics, Nashville, TN). Dynamic parameters of bone
formation were collected using unstained sections from the
trabecular surface in a deﬁned region of interest (100 lM
below the growth plate and 50 lM in from the cortical
bone) using a 920 objective. Bone formation rate (BFR)
was assessed by measuring single-labeled surface for single
perimeter (sL.Pm), double-labeled surface (dL.Pm), and
the interlabel distance in the dL.Pms. The same sections
were then evaluated under polarized white light after
Masson’s trichrome staining to determine static parameters
of bone formation: bone surface (BS), osteoid volume
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then calculated: mineralizing surface (MS/BS, %), mineral
apposition rate (MAR, mM/day), BFR (BFR/BS, MAR 9
[MS/BS]), OV (OV/BS), and (Ob.N/BS), as described
previously [22].
Immunohistochemistry
Alternate sections of the above bones were deplasticized,
rehydrated, and then stained for SDF-1 and CXCR4 using
previously described methods for detecting tissue cytokines
[23]. Speciﬁc antibodies for SDF-1 (rabbit SDF-1a, 1:250
dilution in PBS; Abcam, Cambridge, MA) and CXCR4
(rabbit CXCR4, 1:250 dilution in PBS; Abcam) were used.
Primary antibodies were detected using anti-rabbit sec-
ondary antibodies tagged with Cy2 (green), Cy3 (red), or
HRB (brown after enzymatic reaction with DAB). Sections
were counterstained with DAPI or hematoxylin.
Micro-CT Analysis
High-resolution images of long bones from age-matched
male mice were acquired using a Skyscan 1172, 12 MPix
model (Microphotonics, Allentown, PA). Proximal tibiae
and distal femora were scanned with the source voltage
59 kV, a source current of 167, and an isotropic voxel size
of 6 lm. Imaging started at the distal end of the femur or
the proximal end of the tibiae and included approximately
7 mm (1,335 slices) of the total bone length. After scan-
ning, 3D image data were reconstructed using Sykscan
(Aartselaar, Belgium) NRecon software; structural indices
were calculated using the Skyscan CT Analyzer (CTAn)
software. Using the CTAn software, trabecular bone was
separated from cortical bone with a region of interest tool.
Trabecular morphometric traits were computed from
binarized images using direct 3D techniques that do not
rely on prior assumptions from the underlying structures.
The volume of interest for trabecular microarchitectural
variables was bounded to the endocortical margin, starting
1.9 mm from the proximal tibial condyles, 0.2 mm distal to
the growth plate, in the direction of the metaphysis, and
then extending from this position for 100 slices (0.6 mm).
Upper and lower thresholds of 255 and 80 were used to
delineate each pixel as ‘‘bone’’ or ‘‘nonbone,’’ and tra-
becular bone volume per total volume (BV/TV), BS (BS/
TV), mean trabecular thickness (Tb.Th), mean trabecular
number (Tb.N), and mean trabecular separation (Tb.Sp)
indices were computed. For the analysis of cortical
parameters, the mid-shaft of the femur was determined as
40% of the entire length of the bone. The cortical region of
interest began at the mid-shaft and extended 100 slices
(0.6 mm) toward the femoral head. Using upper and lower
thresholds of 255 and 80, total area (T.Ar), periosteal
perimeter (Ps.Pm), endosteal area (En.Ar), endosteal
perimeter (En.Pm), cortical bone area (Ct.Ar), cortical
thickness (Ct.Th), and relative cortical area (RCA) were
computed.
Mechanical Testing
Breaking strength of the right femur was measured under
three-point bending using a material testing machine
(ElectroForce Systems Group, Bose, Eden Prairie, MN)
ﬁtted with a 1,000 N load cell as previously described
[24, 25]; to minimize the effect of shear loading, the dis-
tance between the lower support points was maximized.
Femora were placed on the loading ﬁxture anterior side
down and loaded in the anterior–posterior plane at a span
length of 19.26 mm. Prior to testing, bones were thawed in
saline at room temperature to ensure hydration. Femora
were loaded to failure at a rate of 0.05 mm/s, during which
displacement and force were collected (100 Hz). Force and
displacement values were normalized using terms derived
from engineering analysis of three-point bending. Bending
moments were calculated from the force (F) data (M = FL/
4) (Nmm). Displacement data were divided by L
2/12 (mm/
mm
2), where L is the distance between the lower supports
(19.26 mm). Whole-bone mechanical properties were then
determined from the moment versus normalized displace-
ment curves, including peak moment (Nmm, ultimate load
the specimen sustained), yield moment (Nmm), stiffness
(Nmm
2, the slope of the initial linear portion of the
moment–displacement curve), yield displacement (mm/
mm
2, displacement at the yield point), postyield displace-
ment (mm/mm
2), work to failure (Nmm-mm/mm
2, the area
under the moment–displacement curve before failure), and
work to failure postyield (Nmm-mm/mm
2). The yield point
was calculated as the point where a 10% change in the
slope of the moment versus normalized displacement curve
occurred.
Cell Culture
Calvarial osteoblasts were obtained from pups 3–5 days
old as previously described [26]. Typically, cells from
three calvaria were plated in T-75 ﬂasks in medium sup-
plemented with 10% FBS. Culture medium was changed
every third day until cells reached conﬂuence. Cells were
harvested and frozen until further use. For osteoblast dif-
ferentiation in a typical experiment, 5 9 10
5 cells were
plated in a 6 cm dish and cultured in the presence of 10%
fetal bovine serum (FBS; Thermo Fisher Scientiﬁc, Pitts-
burg, PA). ‘‘Complete medium’’ is 10% FBS containing
a-MEM. Differentiation of cells in the above medium was
initiated by adding 50 mM ascorbic acid and 5 mM glyc-
erophosphate (Sigma, St. Louis, MO). Osteogenic medium
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123was changed every third day. On day 14 osteoblasts were
stained for alkaline phosphatase (ALP) and assessed for
ALP activity according to the manufacturer’s protocol
(Sigma). ALP activity was normalized to the total protein
content of cell lysates. Protein concentrations were quan-
tiﬁed by a BCA protein assay (Pierce, Rockford, IL). On
day 21 osteoblasts were stained with alizarin red, and
staining was quantiﬁed using the Bioquant Osteo II
(Nashville, TN) program.
Bone marrow stromal cells were isolated from the hind
limbs of mice aged 6–8 weeks. The proximal and distal
ends of the hind limbs were cut to allow the marrow to be
ﬂushed with complete medium. Bone marrow cells were
ﬁltered through a 70 l nylon mesh ﬁlter (BD, Falcon,
Oxnard, CA). Following lysis of RBCs using ammonium
chloride lysis buffer, cells were collected by centrifugation
and resuspended in complete medium. Cells (25 to
30 9 10
7) were plated into T-75 tissue culture ﬂasks.
Nonadherent cells were removed after 16–18 h. Adherent
cells were cultured until they became 70–80% conﬂuent.
Cell culture was treated with 0.025% trypsin containing
0.02% EDTA for 2 minutes at room temperature. To
generate conditioned medium, cells (1 9 10
7) were seeded
in a 6 cm dish and cultured in the presence of complete
medium for 5 days at 37C, 5% CO2. On the ﬁfth day,
medium was removed, centrifuged at 1,500 rpm for 5 min,
ﬁltered through 22 l ﬁlters, and either used immediately or
stored at -80C. Cells were harvested for analysis in
protein markers by real-time PCR as described below. For
colony-forming unit (CFU) assay, bone marrow-derived
cells were used as previously described [27]. Brieﬂy, bone
marrow cells (1.5 9 10
5 cells cm
-2) were plated in com-
plete medium and cultured for 5 days. Then, one-third of
the medium was replaced with complete medium every
third day. After 20 days, cells were ﬁxed with 3.7%
formaldehyde and stained with KaryoMax Giemsa stain or
ALP (Sigma) according to the manufacturer’s protocol.
Cells were visualized using an E300 microscope at 109
magniﬁcation to count the number of colonies. Cells in
clusters of 20 or more were counted as one colony.
For the proliferation assay, 10,000 cells were plated/well
in a 96-well plate in quadruplets. After 18–20 h in culture
in complete medium, cells were washed with serum-free
medium and then incubated with appropriate medium or
growth factors. After 72 h, cells were washed three times
with cold PBS. A proliferation assay was performed using
the Cyquant Cell Proliferation Kit (Molecular Probes,
Eugene, OR) per the manufacturer’s protocol. Fluorescence
was measured using a Wallac 1420 ﬂuorometer (Perkin-
Elmer and Analytical Sciences, Turku, Finland), and cell
proliferation was expressed as a percent of proliferation in
10% FBS-containing medium. In some experiments, prior
to addition to cells, conditioned medium was treated with
appropriate antibodies (10 lg/ml) and this solution was
mixed end on end for 1 h at 4C. In other experiments,
cells were incubated with antibodies (10 lg/ml) for 1 h at
37C prior to the addition of condition medium. Cell
lysates were prepared in mRIPA lysis buffer (50 mM Tris-
HCl [pH 8.0], 150 mM NaCl, 0.5% NP40, 0.25% sodium
deoxycholate, protease inhibitors, 1 mM PMSF, 1 mM
Na2VO3, 50 mM NaF) and lysates were processed for
electrophoresis and Western blotting analysis as previously
described [19].
Real-Time PCR Analysis
The expression levels of osteoblast markers were analyzed
by quantitative real-time PCR. RNA isolation was per-
formed using TRIzol reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer’s protocol. RNA (1 lg) was
transcribed using Super Script II reverse transcriptase
(Invitrogen), following the manufacturer’s protocol. Oli-
go(dT) and dNTPs were purchased from Promega (Madi-
son, WI). Quantitative real-time PCR was performed using
1 ll of cDNA and SYBR Green PCR master mix (Applied
Biosystems, Foster City, CA) on an Applied Biosystems
7500 real-time PCR system. Gene expression levels were
normalized to GAPDH and calculated using the DDCt
method. Primers were designed using mRNA sequences
obtained from Mouse Genomics Informatics and the Primer3
program (http://sourceforge.net/projects/primer3/). The fol-
lowing primers were used: SDF-1, AGTAGTGGCTCCC
CAGGTTT (sense) and GAGACAGTCTTGCGGACACA
(antisense); CXCR4, TCAGTGGCTGACCTCCTCTT
(sense) and TTTCAGCCAGCAGTTTCCTT (antisense);
Col1A, TGAACGTGACCAAAAACCAA (sense) and GCA
GAAAAGGCAGCATTAGG (antisense); RUNX2, CCCA
GCCACCTTTACCTACA (sense) and TATGGAGTGCTG
CTGGTCTG (antisense); BSP, AAAGTGAAGGAAAGCG
ACGA (sense) and GTTCCTTCTGCACCTGCTTC (anti-
sense); GAPDH, AACTTTGGCATTGTGGAAGG (sense)
and ACACATTGGGGGTAGGAACA (antisense).
Analysis of Cytokines
Conditioned medium from bone marrow stromal cells was
generated as described above and then sent for analysis to
Searchlight Aushon Bio Systems (Billerica, MA) to
determine the presence of cytokines and chemokines.
Brieﬂy, a multiplex ELISA was performed using the con-
ditioned medium and the antibody to the protein of interest.
Samples were diluted 1:2, 1:50, and 1:1,000 and tested in
duplicate. A standard curve was established from the
dilutions of the samples. Then, a mean value for the
cytokine of interest was determined from the standard
curve and reported as picograms per milligram total
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performed using the BCA kit. The results of the cytokine
assays were normalized to the protein concentration for
each sample.
Statistics
All experiments were performed at least three times, and
differences between wild type (WT) and YF were deter-
mined using Student’s t test. All statistics were generated
from Prism 4.0 program (GraphPad, San Diego, CA).
Differences were considered signiﬁcant at P\0.05, and
all data are represented as means ± SEM. For mechanical
testing, body weights of mice in each group were nor-
malized with a linear regression–based correction as pre-
viously described [28].
Results
Abrogation of Cbl–PI3K Interaction Results
in Increased Cortical and Trabecular Bone
To understand the role of the Cbl–PI3K interaction in
skeletal remodeling, we employed knock-in mice
(CblY737F/Y737F, henceforth YF mice) in which the
PI3K binding site on Cbl was ablated. Gross analysis
revealed that YF mice were smaller in size and had
decreased body weight compared to control pups (Fig. 1a,
b). The delayed growth was ﬁrst apparent 3 days after birth
(data not shown) and continued for 9–18 days. The delay in
growth occurred simultaneously with a lag in the growth of
long bones (Fig. 1c). Histological analysis of bones from
9-day-old YF pups showed a signiﬁcant delay in the for-
mation of secondary spongiosa (data not shown). Histo-
logical analysis of tibial sections from 12-week-old mice
stained with von Kossa showed that cancellous bone was
increased in YF relative to age-matched control mice
(Fig. 1d). However, weight and total tibial length were
comparable between 12-week-old WT and YF mice
(Fig. 1e, f). YF mice had a slight but signiﬁcant decrease in
body length from tail to snout (Fig. 1g). This matches prior
reports of short stature on postnatal day 9, decreased bone
length, and delayed formation of secondary ossiﬁcation
centers in Cbl
-/- mice [6], although adult Cbl
-/- mice do
not exhibit any overt skeletal phenotype. We also exam-
ined bone architecture of 12-week-old mice by micro-CT
analysis (Fig. 2a, b) and, in agreement with our histological
analysis, found increased trabecular bone volume in YF
mice (Table 1). Similarly, Ct.Ar was signiﬁcantly
increased due to the increased Ps.Pm and Ct.Th in YF mice
(Table 1). Taken together, these results suggest that lack of
interaction between Cbl and PI3K results in increased bone
volume.
Static and Dynamic Parameters of Bone Formation are
Increased in YF Mice
We recently reported that although YF osteoclasts are
unable to resorb bone in vivo, their numbers are signiﬁ-
cantly increased in YF mice [19]. Given that bone volume
can also be increased due to increased osteoblast numbers,
we examined osteoblasts in YF and WT mice. Histological
analysis of tibiae stained with Masson trichome (Fig. 3a)
revealed a signiﬁcant increase in osteoblast numbers and a
63% increase in osteoid (unmineralized bone) in YF sec-
tions (Fig. 3b, c). Histomorphometric analysis of calcein-
labeled sections indicated that the normalized MS/BS,
MAR, and BFR/BS were signiﬁcantly increased in YF
samples (Fig. 3d–g). Taken together, the above results
indicate that in the absence of Cbl–PI3K interaction
increased bone volume in mice is due not only to the
decreased osteoclast-mediated bone resorption reported
previously by our group [19] but also to increased bone
formation by osteoblasts.
Lack of Cbl–PI3K Interaction Confers Increased Bone
While structural changes in bone are most likely to be
detected in trabecular bone, we also observed structural
changes in cortical bone in YF mice. A signiﬁcant increase
in total bone area (P\0.05 vs. WT) as well as increased
Ps.Pm, En.Pm, and En.Ar (P\0.05 vs. WT, each) led to
an increase in overall size of the cortical bone (Table 1).
In addition, polar moment of inertia was signiﬁcantly
greater in YF mice. The RCA did not change between
groups, although there was an overall increase in cortical
thickness (Table 1). Imbalances between bone resorption
and bone formation can affect bone geometry, affecting its
ability to resist damage (fracture). Given that YF mice
have increased cancellous bone (Fig. 1d; Table 1) and
increased cortical bone size (Table 1), we examined the
mechanical properties of the long bones using a three-
point bending assay, as previously described [24, 25].
There was a signiﬁcant increase in peak moment and yield
displacement in YF mice compared to WT, but no dif-
ferences were observed in the other parameters listed in
Table 2. These data suggest that the structural and geo-
metric changes in YF bones could potentially be a com-
pensatory mechanism to maintain bone strength since both
size and the quality of the bone contribute to whole-bone
strength.
400 T. Brennan et al.: Abrogation of Cbl–PI3K Interaction
123In the Absence of Cbl–PI3K Interaction Bone
Marrow-Derived Osteoblasts Show Increased
Col1A Expression
We previously reported that YF mice have increased osteo-
clast numbers and enhanced differentiation [19]. Given that
the numbers ofosteoblasts are also signiﬁcantlyincreasedin
YF mice (Fig. 3b), we next examined if similar increases in
numbers were seen in ex vivo culture conditions. To assess
the ability of osteoblasts to differentiate in vitro, calvarial
osteoblasts or bone marrow stromal cells from WT and YF
mice were treated with osteogenic media for 14 or 21 days.
No appreciable differences were observed in the expression
levels of Col-1A, BSP, and Runx2 between WT- and YF-
derived calvarial osteoblasts and no signiﬁcant differences
wereobservedinALPandvonKossastaining(Fig. 4a–cand
datanotshown).Incontrast,inYFbonemarrowstromalcell
cultures, expression levels of Col1A were signiﬁcantly
increased during differentiation compared to WT samples
(Fig. 4d), while expression levels of BSP and Runx2 were
Fig. 1 Disruption of Cbl–PI3K
interaction results in a growth
delay in young mice. a At
9 days old, YF mice are smaller
than their counterpart WT mice.
Delayed growth in 9-day-old
YF mice resulted in decreased
total body weight (b) and
decreased tibial length (c).
d Representative histological
sections of proximal tibiae of
12-week-old WT and YF mice
stained with von Kossa and
counterstained with toluidine
blue show increased
mineralized bone in YF mice.
Images were taken using a 109
objective. Twelve-week-old
male WT and YF mice have
similar weights (e) and tibial
lengths (f). g Twelve-week-old
YF mice have shorter body
lengths. n = 8 mice per
genotype. Mean ± SEM.
*P\0.05 compared to WT
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of in vitro cultures demonstrated comparable levels of ALP
and alizarin red activity between WT and YF samples
(Fig. 4g–j). Taken together, these data suggest that, unlike
YF osteoclasts, which exhibit enhanced differentiation due
to the upregulation of transcription factors NFATc1 and
NFjB[ 19], for the most part ex vivo osteoblast differentia-
tion and the expression of transcription factor that regulates
osteoblastogenesis are not signiﬁcantly affected in the
absence of Cbl–PI3K interaction.
Osteoblast Proliferation is Upregulated in the Absence
of Cbl–PI3K Interaction
Trabecular and endocortical bone formation are directly cor-
related with the number of marrow-derived osteoprogenitors.
Histological analysis of long bones indicated that in the
absence of Cbl–PI3K interaction there is a twofold increase
in osteoblast numbers (Fig. 3b) and increased MAR
(Fig. 3f). Also, in contrast to calvarial cells, there was a
signiﬁcant increase in the expression of Col-1A when YF
bone marrow-derived stromal cells were cultured in osteo-
genic medium (Fig. 4d). These data suggest that in the
absence of Cbl–PI3K interaction, there might be increased
potentialforthebonemarrowprecursorstodifferentiateinto
osteoblasts and/or that osteoblasts have augmented prolif-
erative capacity. To determine if the numbers of osteoblast
progenitors were affected in YF mice, the number of CFUs
was determined from bone marrow-derived cells. Although,
the total numbers of marrow cells were comparable between
theWTandYFmice(datanotshown),therewasasigniﬁcant
increase in CFUs for YF samples (Fig. 5a) and the potential
of these cells to proliferate was increased compared to WT
cells(Fig. 5b).Wealsoobservedaslight,butnotstatistically
signiﬁcant, increase in the proliferation rate of YF calvarial
osteoblasts (data not shown).
Fig. 2 Disruption of Cbl–PI3K interaction in mice perturbs trabec-
ular and cortical bone architecture. a The trabecular region of
proximal tibiae was scanned starting at the proximal end and included
approximately 7 mm (1,335 slices) of the total bone length. Top and
bottom panels represent a 3D reconstruction of trabecular bone. b The
cortical bone analysis began at 40% from the distal end of the femur
and included 100 sections proximal from that point. Top panel
represents a 3D reconstruction of the cortical bone at mid-shaft.
Bottom panel represents a 2D section of the cortical bone, taken
0.3 mm (50 slices) from the mid-shaft toward the femur. Micro-CT
was performed on six mice per genotype. Representative scanned
images are shown
Table 1 Analysis of trabecular and cortical bone parameters from
12-week-old WT and YF mice
WT YF
Trabecular bone
Bone volume/tissue
volume (BV/TV, %)
9.27 ± 1.69 14.36 ± 1.51*
Bone surface/tissue
volume (BS/TV, %)
9.29 ± 1.11 11.73 ± 0.36*
Trabecular thickness
(Tb. Th., mm)
0.047 ± 0.001 0.056 ± 0.003*
Trabecular number
(Tb. N., 1/mm)
2.00 ± 0.32 2.80 ± 0.17*
Trabecular separation
(Tb. Sp., mm)
0.230 ± 0.021 0.189 ± 0.004*
Cortical bone
Total area (T.Ar, mm
2) 1.50 ± 0.09 1.77 ± 0.08*
Periosteal perimeter
(Ps.Pm (mm)
4.82 ± 0.14 5.18 ± 0.12*
Endosteal area (En.Ar, mm
2) 0.75 ± 0.04 0.88 ± 0.03*
Endosteal perimeter
(En.Pm, mm)
3.26 ± 0.06 3.50 ± 0.09*
Cortical bone area
(Ct.Ar, mm
2)
0.82 ± 0.06 0.95 ± 0.05*
Cortical thickness-2D
(Ct.Th, mm)
0.183 ± 0.006 0.200 ± 0.003**
Relative cortical area (RCA) 0.55 ± 0.02 0.54 ± 0.01
Polar moment of inertia
(J, mm
4)
0.313 ± 0.041 0.424 ± 0.039*
Table represents the parameters of trabecular and cortical bone
obtained through micro-CT analysis. n = 10 mice/genotype. Mean ±
SEM
* P\0.05, ** P\0.01 compared to WT, respectively
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123PI3K is known to regulate cell survival, and we previ-
ously reported that abrogation of Cbl–PI3K resulted in
enhanced osteoclast survival [19]; however, no differences
were observed between the survival of WT and YF bone
marrow-derived stromal cells (Supplementary Fig. 1). We
also examined whether increased proliferation in YF oste-
oblasts was inﬂuenced by extracellular growth factors
known to inﬂuence osteoblast proliferation. Treatment with
several growth factors resulted in a similar level of prolif-
eration in both WT and YF cells (Supplementary Fig. 2a).
In response to addition of EGF, FGF, IGF, and PDGF to the
cultures, phosphorylation of p85 and AKT was comparable
in WT and YF samples (Supplementary Fig. 2b).
In addition to their resorptive activity, osteoclasts are
known to secrete factors that promote anabolic activity
[29, 30]. Since YF mice had increased numbers of osteo-
blasts and osteoclasts (Fig. 3b and [19]), we next examined
the possibility that osteoclast-dependent secretory factors
may promote increased YF osteoblast proliferation. WT
Fig. 3 Bone formation is
increased in YF mice. a Tibial
sections from 12-week-old WT
and YF were stained with
Masson’s trichrome (4009
magniﬁcation). Quantiﬁcation
of osteoblasts/bone surface
(N.Ob/BS) (b) and osteoid/BS
(c). d Dynamic parameters of
bone formation were assessed
using tibiae harvested from
12-week-old WT and YF that
were injected with calcein as
described in Materials and
Methods. Representative
photomicrographs of calcein
double labeling (409)i nW T
and YF in cortical bone (upper
panels) and in trabeculae (lower
panels) are shown.
e Mineralized surface/bone
surface (MS/BS, %). f Mineral
apposition rate (MAR, lm
2/
day). g Bone formation rate/
bone surface (BFR/BS, lm
2/
lm/day). n = 6 mice per
genotype. Mean ± SEM.
*P\0.05, compared to WT
Table 2 Mechanical properties of bone from 12-week-old WT and
YF mice
WT YF
Peak moment (Nmm) 32.30 ± 1.23 38.24 ± 2.75*
Yield moment (Nmm) 28.78 ± 1.41 31.49 ± 2.70
Stiffness (Nmm
2) 1222 ± 74.1 1209 ± 124.4
Yield displacement (mm/mm
2) 0.02 ± 0.001 0.05 ± 0.01*
Postyield displacement (mm/mm
2) 0.004 ± 0.001 0.002 ± 0.002
Work to failure (Nmm*mm/mm
2) 0.61 ± 0.07 0.76 ± 0.16
Work to failure postyield
(Nmm*mm/mm
2)
0.18 ± 0.04 0.22 ± 0.08
Femora were placed on the prongs of a materials testing machine. A
constant load of 0.05 mm/s was applied to femora until bone failure,
during which displacement and force were collected at 100 Hz. Force
and displacement values were normalized using terms as described in
Materials and Methods. Whole-bone mechanical properties were
determined from the moment vs. normalized displacement curves.
n = 10 mice/genotype. Mean ± SEM
* P\0.05 compared to WT
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123and YF osteoclasts were generated in ex vivo cultures as
previously described [19] and the culture medium on day 5
of differentiation was collected. To analyze if the factors
secreted from osteoclasts promote proliferation, MC3T3-
E1 cells were grown in the osteoclast-derived culture
medium. No signiﬁcant differences were observed in the
proliferation rate when cells were cultured in WT osteo-
clast-conditioned medium versus YF osteoclast-condi-
tioned medium (Fig. 5c). This result suggests that, under
these experimental conditions, factors secreted by YF
osteoclasts may not contribute to the observed enhanced
YF osteoblast proliferation.
Increased Levels of SDF-1 in YF Bone Marrow
The bone marrow niche contains a variety of cell types in
various stages of maturation/differentiation. Many of these
cell types secrete factors that can affect osteoblast prolifer-
ation.Therefore,wenextexaminedifotherfactor(s)secreted
by resident bone marrow cells could inﬂuence osteoblast
Fig. 4 Differentiation of
calvarial and bone marrow
stromal cells in ex vivo culture.
a–f WT and YF primary
calvarial or bone marrow
stromal cells were differentiated
in osteogenic media for 0, 14, or
21 days, as indicated.
Osteogenic medium was
changed every third day.
Expression levels of Col-1A (a,
d), BSP (b, e), and Runx-2 (c,
f) were analyzed by real-time
PCR in calvarial osteoblasts
(COB) and bone marrow
stromal cells (BM). g Bone
marrow stromal cells stained for
ALP activity. h ALP activity.
i Bone marrow stromal cells
stained with alizarin red S to
assess calcium deposition.
j Alizarin red S stain was
released from the cell matrix
and quantiﬁed. All experiments
were performed three times. A
representative sample of three
experiments is shown.
Mean ± SEM. *P\0.05
compared to WT
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123proliferation.Forthisexperiment,bonemarrowstromalcells
from WT and YF mice were cultured in the presence of 10%
FBS-containing medium for 5 days. The resulting
supernatant was used as the bone marrow conditioned
medium. Proliferation of MC3T3-E1 cells was examined in
response to WT and YF conditioned media. Compared to
Fig. 5 Proliferation of YF osteoblasts is increased. a Bone marrow
stromal cells were cultured for 20 days in 10% FBS-containing
medium. Cells were ﬁxed and stained with Giemsa; clusters of 20 or
more cells were counted as a colony. b Bone marrow stromal cells
from WT and YF were seeded in a 96-well plate in complete medium
for 72 h, and proliferation was assessed by the Cyquant method, as
described in Materials and Methods. c MC3T3-E1 cells were cultured
in the presence of serum-free medium, 10% FBS, or osteoclast-
conditioned medium derived from WT or YF osteoclasts. Cell
proliferation was assessed as described above. d MC3T3-E1 were
treated with serum-free medium, 10% FBS, or bone marrow
conditioned medium derived from WT or YF bone marrow cultures.
Cell proliferation was assessed as described above. e–h Calvarial and
bone marrow stromal cells were cultured in complete medium for
5 days. Expression levels of SDF-1 (e, g) and CXCR4 (f, h) were
measured by quantative real-time PCR. Data are presented as fold
difference of expression between WT and YF culture. All experi-
ments were performed three times, and a representative is shown.
Mean ± SEM. *P\0.05 compared to WT
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123WT, treatment with YF conditioned medium induced
increased proliferation of MC3T3-E1 cells (Fig. 5d), sug-
gesting that a factor(s) present in the YF bone marrow-
derived medium might contribute to the increased cell
proliferation.
Analysis of the conditioned media using multiplex
ELISAs indicated that the levels of IL-1b, IL-18, MCP-1,
RANTES, and TGF-1b were comparable in WT and YF
samples (Table 3). Only levels of SDF-1, a chemokine
known to be present in the bone marrow milieu, were
signiﬁcantly increased in the YF bone marrow conditioned
medium (Table 3). We next determined mRNA expression
levels of SDF-1 and its receptor, CXCR4, in calvarial
osteoblasts and bone marrow stromal cells. For these
experiments, cells were cultured in the presence of 10%
FBS for 5 days before harvesting. RT-PCR analysis
showed that SDF-1 and CXCR4 levels were comparable in
WT and YF calvarial cells (Fig. 5e, f). In contrast, com-
pared to expression levels in WT bone marrow stromal
cells, YF bone marrow stromal cells showed *2.5- and
3.5-fold increases in the expression levels of SDF-1 and
CXCR4, respectively (Fig. 5g, h). This expression was
then veriﬁed by immunohistochemistry. Staining of YF
tibial sections with anti-SDF-1 antibodies showed
enhanced staining in many bone stromal cells but no
staining in mature osteoblasts adjacent to the trabeculae
(Fig. 6b, c, i). Both stromal cells and osteocytes in sections
from YF samples demonstrated increased CXCR4 staining
compared to WT samples (Fig. 6f, j, h, l). For validation,
bone marrow proliferation assays were performed
using neutralizing antibodies against SDF-1 or CXCR4.
Enhanced proliferation of MC3T3-E1 cells in response to
YF conditioned medium was signiﬁcantly decreased in the
presence of neutralizing antibodies (Fig. 7). Taken toge-
ther, these data suggest that in YF mice cell proliferation is
increased, at least in part, due to increased SDF-1 present
in the bone marrow milieu. However, our results do not
eliminate the possibility that other factors may also con-
tribute to the increased osteoblast proliferation.
Discussion
Cbl proteins are known to play a role in osteoclast
migration and function as well as in osteoblast differenti-
ation downstream of the FGF pathway by ubiquitylating
and degrading the Src family kinases Lyn and Fyn [31, 32].
However, loss of Cbl protein in adult mice did not result in
an overt skeletal phenotype [6]. On the other hand, absence
of Cbl-b, another member of the Cbl family, resulted in
decreased bone volume [7]. These ﬁndings suggest that
although Cbl and Cbl-b proteins share signiﬁcant homol-
ogies and identical domain organization [2], they have
different effects on cells that regulate bone mass. One
major difference between the two proteins is the absence of
Y737 in Cbl-b. Cbl protein phosphorylation of Y737 has
been shown to recruit PI3K and regulate PI3K activity [16].
Studies on osteoblast cell lines have established that PI3K
plays an important role in osteoblast function [15, 33, 34].
In an immortalized human osteoblast cell line, FGFR2–Cbl
interaction in lipid rafts resulted in attenuation of PI3K
signaling and osteoblast survival [18]. We recently repor-
ted that the lack of Cbl–PI3K interaction promotes
decreased osteoclast function while increasing their sur-
vival [19]. In this report, we examined if the lack of this
molecular interaction also had an effect on osteoblast dif-
ferentiation and function.
Cbl is a major PI3K binding protein in several cell
types. With a Y[F mutation on the Cbl–PI3K binding
site, the expectation is that loss of this interaction would
perturb PI3K-mediated signaling and cell survival. In
thymocytes loss of Cbl–PI3K results in decreased AKT
phosphorylation [35], whereas in osteoclasts abrogation of
this interaction results in increased AKT phosphorylation,
leading to enhance survival [19]. Others have shown that
in human osteoblast cells that express mutated forms of
FGFR2 FGFR2–Cbl interaction in lipid rafts triggers
attenuation of PI3K/AKT signaling and osteoblast survival
[18]. On the other hand, stimulation of growth factor
receptors in YF osteoblasts did not modulate proliferation
or PI3K-mediated signaling (Supplementary Fig. 2a, b).
Thus, it appears that Cbl–PI3K interaction plays distinct
roles in different cell types. In YF osteoblasts, the lack of
impact on PI3K-mediated signaling suggests that Cbl-b
and/or other proteins (e.g., Src) that are capable of inter-
acting with PI3K might be able to compensate for the lack
of Cbl–PI3K interaction and preserve the signaling. It is
also likely that another SH2 domain-containing protein
Table 3 Expression of cytokines in WT and YF bone marrow-
derived conditioned medium
WT YF
IL-1b 0.003 ± 0.0005 0.004 ± 0.0005
IL-18 0.02 ± 0.007 0.02 ± 0.005
MCP-1 1.48 ± 0.80 1.11 ± 0.83
RANTES 0.01 ± 0.009 0.008 ± 0.002
TGF-b1 4.44 ± 0.70 4.71 ± 1.54
SDF-1 0.04 ± 0.01 0.10 ± 0.03*
Table represents levels for each protein tested using a multiplex
ELISA. The concentration of each factor was normalized to the total
amount of protein present in the conditioned medium for each sample
and expressed as picograms of cytokine per micrograms of protein.
Mean ± SEM
* P\0.05 compared to WT
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123might interact with phosphorylated Y737 Cbl and that the
observed effects in the YF mice are a consequence of loss
of that interaction.
Histological and micro-CT analysis of bones from YF
mice indicated that there was an increase in trabecular bone
volume (Fig. 2; Table 1), osteoblast numbers (Fig. 3b),
BFR, mineralizing surface, and MAR compared to WT
mice (Fig. 3e–g). Also, culturing YF bone marrow stromal
cells resulted in increased numbers of CFUs and increased
proliferation (Fig. 5a, b). The increase in Col1A expression
during differentiation of YF bone marrow cells (Fig. 4d)
suggests that the increase in MAR is driven at least in part
by increased matrix protein production. However, other
markers of differentiation were unaffected in YF bone
marrow cells (Fig. 4). These combined data suggest that
the increased numbers of YF osteoblasts in bone marrow
may be in part also due to a secondary effect.
The increased bone volume and increased numbers of
nonresorbing osteoclasts and osteoblasts are indicative
of an osteopetrotic phenotype in YF mice (Fig. 2 and
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bone resorption is compromised due to the absence of
osteoclast (c-Fos
-/-)[ 37] or due to impaired osteoclast
function (e.g., Src
-/- [38] and Pyk2
-/- [39]), bone for-
mation is also impaired due to a cell autonomous defect in
osteoblast activity [37, 40, 41]. In v-ATPase knockout
mice, in which osteoclasts are incapable of degrading the
bone matrix, both bone formation and osteoblast numbers
increase due to uncoupling [42]. Osteoclast activity has
been regarded as restricted to bone resorption; however,
recent studies have suggested that osteoclasts might release
anabolic signals that are not linked to their resorption
activity [29, 30]. Our results indicate that cell proliferation
was not signiﬁcantly affected when cells were grown in
conditioned medium generated from YF osteoclasts
(Fig. 5c). This could be due to several possibilities. First, in
an ex vivo culture system, a secreted factor(s) may not be
in sufﬁcient quantity or concentration to inﬂuence cell
proliferation. Second, cell–cell contact between osteoclasts
and osteoblasts may be required for the desired effect on
proliferation since direct contact of osteoblasts with the
bone marrow precursors is a prerequisite for the generation
of mature osteoclasts and to facilitate interaction of the
membrane-bound RANKL on osteoblasts with RANK on
osteoclasts [43]. Furthermore, recent studies have indicated
that the interaction between the transmembrane ephrinB2
ligand that is present on osteoclasts mediates anabolic
signals via the ephB4 receptor present on osteoblasts [44].
Given that YF osteoclasts are not functional in in vivo and
in vitro cultures [19], we could not test the possibility that a
bone matrix-derived factor(s) could inﬂuence increased
proliferation of osteoblasts in vivo. Given this scenario, it
is not likely that YF osteoclasts modulate enhanced pro-
liferation of YF osteoblasts, although more studies are
needed to explore this further.
Bone marrow contains several different types of hema-
topoietic and stromal cells that secrete a variety of growth
factors and cytokines that can inﬂuence the properties of
cells residing in the marrow space [45, 46]. Our result show
that there was a signiﬁcant increase in the rate of prolif-
eration of MC3T3-E1 cells cultured in YF conditioned
medium compared to WT conditioned medium (Fig. 5d).
Comparative analysis of WT and YF condition media
showed that the level of the chemokine SDF-1 was ele-
vated in the YF conditioned medium (Table 3). SDF-1,
also known as CXCL2, is produced in bone marrow stro-
mal cells and directs the migration of hematopoietic cells
to the bone marrow during development [47]. The SDF-1/
CXCR4 signaling axis is essential for several normal
physiological functions, including bone remodeling [48].
For example, SDF-1 has been implicated as a regulator of
bone resorption [49]. SDF-1 also regulates BMP2-mediated
osteogenic differentiation in mesenchymal cell lines [50].
Fig. 7 Increased proliferation of cells in YF conditioned medium is
mediated by SDF-1. MC3T3-E1 cells were cultured in the presence of
serum-free medium, 10% FBS, or condition medium derived from
WT or YF bone marrow cells. To assess the effect of SDF-1, 10 lg/
ml of neutralizing anti-SDF-1 antibodies or isotype control antibodies
was added to the conditioned medium. To determine the role of
CXCR4, MC3TC-E1 cells were pretreated with 10 lg/ml neutralizing
anti-CXCR4 antibodies. The cell proliferation assay was performed as
described above. Cell proliferation is expressed as a percent of control
(10% FBS-treated cells). Mean ± SEM. Symbols indicate P\0.05
for the following comparisons: a FBS versus YF, b WT versus YF,
c YF versus IgG, d YF versus YF ? a-SDF-1, e IgG versus YF ?
a-SDF-1, f YF versus YF ? a-CXCR4, g IgG versus YF ? a-CXCR4
Fig. 6 Bone marrow stromal cells from YF mice show enhanced
SDF-1 and CXCR4 expression. Representative sections of proximal
tibiae from 12-week-old WT and YF immunostained with either anti-
SDF-1a (HRP-DAB or secondary antibody tag), anti-CXCR4, or
DAPI. In all images, area indicated with asterisk is enlarged in inset.
a WT tibial section showing only low-level SDF-1 staining in bone
marrow stromal cells. Inset shows an absence of SDF-1 staining in
osteocytes or quiescent bone lining cells on trabecular bone. b YF
tibial section showing SDF-1 staining in many bone stromal cells.
Inset shows SDF-1 staining in many stromal cells, including cells
surrounding the trabecular bone, but no staining in osteoblasts (ob).
Sections in a and b are lightly counterstained with hematoxylin and
eosin (H&E). c YF tibial section with SDF and DAPI labeling
showing SDF-1-stained cells in the bone marrow (bm) but not in cells
lining the trabecular bone (tb). d YF tibial cortical bone showing
increased numbers of osteocytes (os) expressing CXCR4. e WT tibial
section showing SDF-1 staining in only a few of bone marrow cells
but no staining in trabecular bone. Inset shows SDF-1 staining in only
a few stromal cells. f Same section as shown in e showing an absence
of CXCR4 staining. g Same section showing DAPI staining.
h Merged e–g panels. Inset shows a low number of SDF ? DAPI-
stained stromal cells. i YF tibial section showing high levels of SDF-1
staining in many bone marrow stromal cells but none in trabecular
bone. Inset shows SDF-1 in the cytoplasm of these cells. j Same
section as in i showing increased CXCR4 staining in several stromal
cells. Some, but not all, of the CXCR4-stained cells are double-
labeled with SDF-1. Inset shows CXCR4 staining in the same cells as
shown in inset in i. k Same section showing DAPI staining. l Merged
i–k panels. Inset shows SDF ? DAPI-stained stromal cells. All
images were taken using a 409 objective. Scale bar in l = 20 lm. bv,
blood vessel
b
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123More recently, it has been demonstrated that conditional
inactivation of CXCR4 in osteoblast precursors reduces
postnatal bone formation due to impaired osteoblast
development [51]. Our results show that expression of both
SDF-1 and CXCR4 was substantially increased in YF bone
marrow stromal cells (Fig. 6). In contrast, SDF-1 was not
increased in mature osteoblast and bone lining cells
(Fig. 6c, d). Interestingly, the increased expression was
restricted to the YF bone marrow milieu since expression
levels of SDF-1 and CXCR4 were comparable in WT and
YF calvarial cells (Fig. 5e, f). It is likely that increased
SDF-1 in the YF bone marrow environment promotes
osteoblast proliferation since both Cbl [52] and PI3K [53]
are known to participate in SDF-1-mediated signaling.
Further studies are needed to speciﬁcally analyze the role
of Cbl–PI3K interaction in the effects of SDF-1-mediated
signaling events that induce proliferation, attachment, and
migration of bone marrow stromal cells.
In conclusion, our studies establish that abrogation of
Cbl–PI3K interaction results in increased bone volume.
While our past studies show that this is primarily due to
defective osteoclast function, these new data also suggest
that the increased numbers of osteoblasts in vivo and
increased proliferation of osteoblasts are due to a second-
ary effect probably mediated by factors in the marrow
cavity, such as SDF-1.
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